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HTLV-1 carriers and the patients with adult T-cell
leukemia (ATL) frequently suffer from the opportunis-
tic infections. Although it has been known that HTLV-
1 infection evokes cell-mediated immune deficiency, its
mechanism remains unknown. HTLV-1 bZIP factor
(HBZ) is encoded in the minus strand of HTLV-1,
which is constitutively expressed and involved in the
proliferation of HTLV-1-infected cells. In this study,
we investigated the role of HBZ in immunodeficiency
in a mice model. HBZ transgenic (HBZ-Tg) mice were
infected with HSV-2 and Listeria monocytogenes and
evaluated for cellular immunity to those pathogens.
The clearance of both pathogens was impaired in
HBZ-Tg mice compared with the non-transgenic litter-
mate. In the both infection, production of IFN-gamma
in CD4+ T cells was significantly reduced in HBZ-Tg
mice. In addition, ectopic expression of HBZ in pri-
mary human CD4+ T cells impaired IFN-gamma pro-
d u c t i o ni nv i t r o .A st h em o l e c u l a rm e c h a n i s m s ,w e
found that HBZ suppressed transcription of IFNG pro-
moter. Our results suggestt h a tH B Zp l a y sac r u c i a l
role for cellular immunodeficiency in HTLV-1-infected
subjects.
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